Four Segments of Albius Sciences
Our own proprietary novel small molecule drug design technology (including AI technology and 3D modelling).
A dynamic and versatile compound library, created with advanced chemical technique, resulting in discovery of brand new chemical spaces.
Multiple pipelines of small molecule drug R&D for chronic or hard-to-treat diseases, including fibrosis, respiratory syncytial virus and corona virus.
Multiple pipelines of small molecule drug R&D for target diseases, including feline infectious peritonitis, feline chronic renal failure and avian flu.